tetano
Editor, Senior Moderator
J Virol
. 2025 May 6:e0048225.
doi: 10.1128/jvi.00482-25. Online ahead of print. Characterization of SARS-CoV-2 intrahost genetic evolution in vaccinated and non-vaccinated patients from the Kenyan population
Doreen Lugano[SUP] 1 2 3 [/SUP], Kennedy Mwangi[SUP] 1 [/SUP], Bernard Mware[SUP] 1 [/SUP], Gilbert Kibet[SUP] 1 [/SUP], Shebbar Osiany[SUP] 1 [/SUP], Edward Kiritu[SUP] 1 [/SUP], Paul Dobi[SUP] 1 [/SUP], Collins Muli[SUP] 1 [/SUP], Regina Njeru[SUP] 1 [/SUP], Tulio de Oliveira[SUP] 4 [/SUP], M Kariuki Njenga[SUP] 5 6 [/SUP], Andrew Routh[SUP] 2 7 [/SUP], Samuel O Oyola[SUP] 1 [/SUP]
Affiliations
Vaccination is a key control measure of coronavirus disease 2019 by preventing severe effects of disease outcomes, reducing hospitalization rates and death, and increasing immunity. However, vaccination can affect the evolution and adaptation of SARS-CoV-2 largely through vaccine-induced immune pressure. Here, we investigated intrahost recombination and single nucleotide variations (iSNVs) on the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) genome in non-vaccinated and vaccinated sequences from the Kenyan population to profile intrahost viral genetic evolution and adaptations driven by vaccine-induced immune pressure. We identified recombination hotspots in the S, N, and ORF1a/b genes and showed the genetic evolution landscape of SARS-CoV-2 by comparing within- and inter-wave recombination events from the beginning of the pandemic (June 2020 to December 2022) in Kenya. We further reveal differential expression of recombinant RNA species between vaccinated and non-vaccinated individuals and perform an in-depth analysis of iSNVs to identify and characterize the functional properties of non-synonymous mutations found in ORF-1 a/b, S, and N genes. Lastly, we detected a minority variant in non-vaccinated patients in Kenya, with an immune escape mutation S255F of the spike gene, and showed differential recombinant RNA species. Overall, this work identified unique in vivo mutations and intrahost recombination patterns in SARS-CoV-2, which could have significant implications for virus evolution, virulence, and immune escape.IMPORTANCEThe impact of vaccination on severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) genetic diversity in Kenya and much of Africa remains unknown. This can be attributed to lower sequencing rates; however, this information is relevant to improvement in vaccine and antiviral research. In this study, we investigated how vaccination and SARS-CoV-2 transmission waves affect intrahost non-homologous recombination and single nucleotide variations (iSNVs). We identified unique in vivo mutations and intrahost recombination patterns in SARS-CoV-2, which could have significant implications for virus evolution, virulence, and immune escape. We also demonstrate a methodology for studying genetic changes in a pathogen by a simultaneous analysis of both intrahost single nucleotide variations and recombination events. The study reveals the diversity of SARS-CoV-2 in Kenya and highlights the need for sustained genomic surveillance in Kenya and Africa to better understand how the virus evolves. Such surveillance ensures detection of drifts in evolution, allowing information for updates in vaccines, policy making, and containment of future variants of SARS-CoV-2.
Keywords: SARS-CoV-2; intrahost recombination; intrahost single nucleotide variations (iSNV); non-homologous recombination; non-vaccinated; unique mutations; vaccination; viral recombination.
. 2025 May 6:e0048225.
doi: 10.1128/jvi.00482-25. Online ahead of print. Characterization of SARS-CoV-2 intrahost genetic evolution in vaccinated and non-vaccinated patients from the Kenyan population
Doreen Lugano[SUP] 1 2 3 [/SUP], Kennedy Mwangi[SUP] 1 [/SUP], Bernard Mware[SUP] 1 [/SUP], Gilbert Kibet[SUP] 1 [/SUP], Shebbar Osiany[SUP] 1 [/SUP], Edward Kiritu[SUP] 1 [/SUP], Paul Dobi[SUP] 1 [/SUP], Collins Muli[SUP] 1 [/SUP], Regina Njeru[SUP] 1 [/SUP], Tulio de Oliveira[SUP] 4 [/SUP], M Kariuki Njenga[SUP] 5 6 [/SUP], Andrew Routh[SUP] 2 7 [/SUP], Samuel O Oyola[SUP] 1 [/SUP]
Affiliations
- PMID: 40326760
- DOI: 10.1128/jvi.00482-25
Vaccination is a key control measure of coronavirus disease 2019 by preventing severe effects of disease outcomes, reducing hospitalization rates and death, and increasing immunity. However, vaccination can affect the evolution and adaptation of SARS-CoV-2 largely through vaccine-induced immune pressure. Here, we investigated intrahost recombination and single nucleotide variations (iSNVs) on the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) genome in non-vaccinated and vaccinated sequences from the Kenyan population to profile intrahost viral genetic evolution and adaptations driven by vaccine-induced immune pressure. We identified recombination hotspots in the S, N, and ORF1a/b genes and showed the genetic evolution landscape of SARS-CoV-2 by comparing within- and inter-wave recombination events from the beginning of the pandemic (June 2020 to December 2022) in Kenya. We further reveal differential expression of recombinant RNA species between vaccinated and non-vaccinated individuals and perform an in-depth analysis of iSNVs to identify and characterize the functional properties of non-synonymous mutations found in ORF-1 a/b, S, and N genes. Lastly, we detected a minority variant in non-vaccinated patients in Kenya, with an immune escape mutation S255F of the spike gene, and showed differential recombinant RNA species. Overall, this work identified unique in vivo mutations and intrahost recombination patterns in SARS-CoV-2, which could have significant implications for virus evolution, virulence, and immune escape.IMPORTANCEThe impact of vaccination on severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) genetic diversity in Kenya and much of Africa remains unknown. This can be attributed to lower sequencing rates; however, this information is relevant to improvement in vaccine and antiviral research. In this study, we investigated how vaccination and SARS-CoV-2 transmission waves affect intrahost non-homologous recombination and single nucleotide variations (iSNVs). We identified unique in vivo mutations and intrahost recombination patterns in SARS-CoV-2, which could have significant implications for virus evolution, virulence, and immune escape. We also demonstrate a methodology for studying genetic changes in a pathogen by a simultaneous analysis of both intrahost single nucleotide variations and recombination events. The study reveals the diversity of SARS-CoV-2 in Kenya and highlights the need for sustained genomic surveillance in Kenya and Africa to better understand how the virus evolves. Such surveillance ensures detection of drifts in evolution, allowing information for updates in vaccines, policy making, and containment of future variants of SARS-CoV-2.
Keywords: SARS-CoV-2; intrahost recombination; intrahost single nucleotide variations (iSNV); non-homologous recombination; non-vaccinated; unique mutations; vaccination; viral recombination.